Does low skeletal muscle mass reduce insulin-stimulated glucose disposal and increase insulin resistance?

Skeletal muscle functions as the body's primary "metabolic sink," responsible for approximately 80% of insulin-stimulated glucose disposal. Consequently, any significant reduction in skeletal muscle mass—a condition frequently observed in aging individuals—directly compromises the body's ability to clear glucose from the bloodstream and maintain metabolic homeostasis.

Clinical and metabolic evidence

Data from gold-standard hyperinsulinemic-euglycemic clamp studies consistently show that lower lean body mass is a significant predictor of reduced whole-body glucose disposal rates (Rd). Longitudinal research indicates that a decline in the skeletal muscle mass index is associated with a markedly increased risk of type 2 diabetes, with hazard ratios of approximately 1.36 per standard deviation decline. In geriatric populations, sarcopenia often precedes the clinical diagnosis of metabolic syndrome, highlighting low muscle mass as a primary driver of insulin resistance rather than a secondary symptom.

Mechanistic explanations

The link between low muscle mass and insulin resistance is driven by several convergent cellular pathways:

• Reduced GLUT4 capacity: A reduction in muscle fibers decreases the total quantity of GLUT4 transporters available for translocation to the cell membrane, effectively shrinking the "metabolic surface area" available for glucose uptake.
• Lipotoxicity and signaling interference: Sarcopenia is frequently accompanied by myosteatosis (intermuscular fat infiltration) and mitochondrial dysfunction. This leads to the accumulation of intramyocellular lipids, such as ceramides and diacylglycerols, which inhibit the critical IRS-1/PI3K/Akt insulin signaling pathway.
• Myokine depletion: Skeletal muscle acts as an endocrine organ. Loss of mass reduces the secretion of protective myokines like irisin and myonectin, which normally enhance insulin sensitivity and mitochondrial biogenesis.

Bottom line

Lower skeletal muscle mass directly reduces glucose disposal capacity and increases systemic insulin resistance through both physical reduction of glucose-clearing tissue and the disruption of cellular insulin signaling. For aging adults, preserving muscle mass is a critical requirement for maintaining glycemic control.